# Xilio Therapeutics, Inc.: Form 8-K, filed Sep 13, 2024

- Company: [Xilio Therapeutics, Inc.](/companies/xlo.md) (CIK 1840233)
- Form: 8-K
- Filed: 2024-09-13
- Accepted by EDGAR: Sep 13, 2024, 20:16 ET
- Period: 2024-09-10
- Accession: 0001558370-24-012775
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840233/000155837024012775/xlo-20240910x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840233/000155837024012775/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840233/000155837024012775/xlo-20240910x8k.htm

Filed Sep 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-012775. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.